We are live on
!
Find out more
SOCM
SR One Capital Management Portfolio holdings
AUM
$915M
1-Year Est. Return
209.71%
This Fund
S&P 500
1 Year Est. Return
+209.71%
AUM
$915M
AUM Growth
+$209M
(+30%)
Holding
14
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ACLX
1
DELISTED
Arcellx
ACLX
| $269M | 29.43% |
2,346,630
|
|
||
|
MANE
2
Veradermics Inc
MANE
$4.9B
| $152M | 16.57% |
+2,401,868
|
|
||
|
ZBIO
3
Zenas BioPharma
ZBIO
$1.38B
| $98.5M | 10.76% |
5,037,854
|
|
||
4
CRISPR Therapeutics
CRSP
$5.32B
| $97M | 10.59% |
2,038,763
|
|
||
5
Design Therapeutics
DSGN
$861M
| $69.4M | 7.59% |
6,526,476
|
|
||
6
Oric Pharmaceuticals
ORIC
$979M
| $58.5M | 6.39% |
4,514,929
|
|
||
|
ALMS
7
Alumis Inc
ALMS
$3.19B
| $43.2M | 4.72% |
1,959,896
|
|
||
8
Mineralys Therapeutics
MLYS
$2.27B
| $42.4M | 4.63% |
1,563,966
|
|
||
9
ARS Pharmaceuticals
SPRY
$1.05B
| $32.2M | 3.52% |
4,012,903
|
|
||
|
ORKA
10
Oruka Therapeutics
ORKA
$5.22B
| $21.1M | 2.31% |
430,330
|
|
||
11
Oculis Holding
OCS
$698M
| $17M | 1.86% |
641,022
|
|
||
12
Nkarta
NKTX
$207M
| $7.03M | 0.77% |
3,333,333
|
|
||
13
enGene Therapeutics
ENGN
$119M
| $5.09M | 0.56% |
747,750
|
|
||
14
Ultragenyx Pharmaceutical
RARE
$2.87B
| $2.89M | 0.32% |
137,753
|
|